Stocks · Healthcare · Medical - Devices
Outset Medical, Inc. OM
$3.96 +5.60% Close, Oct 2, 2026 · NASDAQ · Market cap $73.4M
Weak trendHigh risk
Next earnings report: Nov 9, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to -56.1% from -66.2% a year earlier.
- Over the past year the stock returned -71.8%, behind the S&P 500 by 86.8 percentage points.
- The stock is 75% below its highest close of the past year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 28%
- Revenue growth, 3-year CAGRBottom 26%
- Revenue growth accelerationBottom 30%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 39%
- Gross marginBottom 27%
- Operating marginBottom 34%
- Accruals (lower is better)Top 23%
- Interest coverBottom 42%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 6%
- Free-cash-flow yieldBottom 8%
- EBITDA / enterprise valueBottom 17%
- Sales / enterprise valueTop 13%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 1%
- 6-month returnBottom 42%
- 1-year return vs S&P 500Bottom 3%
- Distance from 52-week highBottom 6%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 28%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyBottom 29%
- Upside to consensus price targetTop 13%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 23%
- Maximum drawdown, 3 yearsBottom 2%
- Beta vs S&P 500 (lower is better)Bottom 12%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 2.0% | -1.3% | ↓ |
| Gross margin | 36.5% | 41.8% | ↑ |
| Operating margin | -66.2% | -56.1% | ↑ |
| FCF margin | -57.3% | -33.0% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -1.3% | 2.0% | ↓ | Bottom 28% |
| Gross margin | 41.8% | 36.5% | ↑ | Bottom 27% |
| Operating margin | -56.1% | -66.2% | ↑ | Bottom 34% |
| Net margin | -63.1% | -82.1% | ↑ | — |
| Free-cash-flow margin | -33.0% | -57.3% | ↑ | — |
| Return on invested capital | -32.8% | — | Bottom 39% | |
| Revenue growth, 3-year CAGR | 1.2% | — | Bottom 26% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -14.8%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 13.0%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -15.0 pp
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -4.8×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.31%
- Shareholder yield
- -0.31%
- Share count change, 1 year
- +4.9%
- Share count change, 3-year CAGR
- +78.7%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 2 of 8
- Average EPS surprise, last 4
- -11.7%
- Average 2-day reaction, last 8
- -0.1%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $14.00
- Target vs current price
- +253.5%
- Analysts with a rating
- 11
- Share rating Buy or Strong Buy
- 64%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | -11.6% | +1.6% | -12.1% | -28.3% | — |
| May 7, 2026 | -5.1% | +3.8% | -13.7% | +4.9% | +10.6% |
| Feb 11, 2026 | -24.7% | -3.4% | -26.2% | -30.6% | -0.4% |
| Nov 10, 2025 | -5.3% | +0.1% | -61.2% | -64.0% | -63.6% |
| Aug 6, 2025 | +14.5% | -6.6% | -10.1% | -2.3% | -4.4% |
| May 7, 2025 | -242.9% | +1.7% | +49.4% | +67.4% | +30.3% |
| Feb 19, 2025 | +10.5% | +3.5% | -9.9% | -39.4% | +35.8% |
| Nov 6, 2024 | -1362.5% | -1.2% | +36.9% | +89.7% | +30.7% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.80 | -$0.72 | -11.6% | $31.6M |
| May 7, 2026 | -$0.83 | -$0.79 | -5.1% | $27.9M |
| Feb 11, 2026 | -$0.84 | -$0.67 | -24.7% | $28.9M |
| Nov 10, 2025 | -$0.69 | -$0.66 | -5.3% | $29.4M |
| Aug 6, 2025 | -$0.84 | -$0.98 | +14.5% | $31.4M |
| May 7, 2025 | -$3.24 | -$0.95 | -242.9% | $29.8M |
| Feb 19, 2025 | -$5.55 | -$6.20 | +10.5% | $29.5M |
| Nov 6, 2024 | -$5.85 | -$0.40 | -1362.5% | $28.7M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 1.21× | — | — | Top 13% |
| Free-cash-flow yield | -52.96% | — | — | Bottom 8% |
| Earnings yield | -103.28% | — | — | Bottom 6% |
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 1
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -11.0%
- 200-day average slope (20 days)
- -2.7%
- Distance from 50-day average
- +0.3%
- Distance from 200-day average
- -4.5%
- RSI (14)
- 63.1
- Relative volume
- 2.60×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 74.7%
- Volatility vs own 5-year history
- 32th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 2.06
- Correlation with S&P 500
- 0.32
- Current drawdown from 1-year high
- -75.0%
- Maximum drawdown, 3 years
- -98.2%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Nov 30, 2020 | Sep 28, 2026 | -99.7% | 1462 days | Not yet recovered |
| Sep 25, 2020 | Oct 9, 2020 | -17.9% | 10 days | 25 days (Nov 13, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $73.4M
- EPS, diluted (TTM)
- -$4.09
- Revenue (TTM)
- $117.8M
- 52-week range
- $2.84 – $16.16
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $102.6M | $115.4M | $130.4M | $113.7M | $119.5M |
| Gross profit | $7.6M | $17.8M | $29.0M | $38.6M | $46.8M |
| Operating income | -$130.5M | -$161.0M | -$169.8M | -$113.4M | -$66.7M |
| Net income | -$131.9M | -$163.0M | -$172.8M | -$128.0M | -$81.7M |
| EPS (diluted) | -$43.41 | -$50.75 | -$52.27 | -$36.95 | -$5.37 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $28.7M | $29.5M | $29.8M | $31.4M | $29.4M | $28.9M | $27.9M | $31.6M |
| Net income | -$27.9M | -$25.6M | -$25.8M | -$18.5M | -$17.8M | -$19.5M | -$19.0M | -$18.0M |
| EPS (diluted) | -$8.30 | -$7.35 | -$7.44 | -$1.04 | -$1.00 | -$1.09 | -$1.03 | -$0.97 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$130.3M | -$145.7M | -$131.4M | -$116.3M | -$46.3M |
| Capital expenditure | -$3.1M | -$8.3M | -$3.4M | -$912,000 | -$798,000 |
| Free cash flow | -$133.4M | -$154.1M | -$134.8M | -$117.2M | -$47.1M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $149.1M | $8.0M | $10.4M | $2.3M | $162.2M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $147.2M
- Total assets
- $242.4M
- Total liabilities
- $146.0M
- Total debt
- $104.4M
- Net debt
- $69.4M
- Shareholders’ equity
- $96.3M
As of Jun 30, 2026 (filed Aug 6, 2026).
Short interest
- Shares sold short
- 889,575
- Days to cover
- 6.18
- Change vs previous report
- -1.3%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Mar 20, 2025
- 1-for-15